Cargando…
Long non-coding RNA SENCR alleviates the inhibitory effects of rapamycin on human umbilical vein endothelial cells
Rapamycin (RPM) is frequently used as the drug coating in drug-eluting stents (DESs) as it can inhibit the growth of smooth muscle cells. However, RPM also inhibits the proliferation and migration of vascular endothelial cells, and impairs reendothelialization in DES implantation. Therefore, the dev...
Autores principales: | Sun, Hongtao, Wang, Shuiyun, Song, Min |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6072185/ https://www.ncbi.nlm.nih.gov/pubmed/29845247 http://dx.doi.org/10.3892/mmr.2018.9094 |
Ejemplares similares
-
Long non-coding RNA SENCR alleviates endothelial-to-mesenchymal transition via targeting miR-126a
por: Lou, Chuang, et al.
Publicado: (2020) -
A Role for the Long Noncoding RNA SENCR in Commitment and Function of Endothelial Cells
por: Boulberdaa, Mounia, et al.
Publicado: (2016) -
Association of the rs555172 polymorphism in SENCR long non-coding RNA and atherosclerotic coronary artery disease
por: Shahmoradi, Nahid, et al.
Publicado: (2017) -
Rapamycin Regulates the Expression and Activity of Krüppel-Like Transcription Factor 2 in Human Umbilical Vein Endothelial Cells
por: Ma, Qian, et al.
Publicado: (2012) -
Long Non-coding RNA MEG3 Attenuates the Angiotensin II-Induced Injury of Human Umbilical Vein Endothelial Cells by Interacting With p53
por: Song, Jingwen, et al.
Publicado: (2019)